However, only genetic and pharmacological inhibition of p38 is able to revert the increase of SOX2 protein induced by PLX4032, suggesting p38 as a major compensatory mechanism responsible for BRAFi-induced increase of SOX2 in melanoma cells. The gene discussed is SOX2; the disease is melanoma.